Sort   by:  
 Page size 
ProteomicsIn situ valence-transited arsenic nanosheets for multi-modal therapy of colorectal cancer
Late-stage and advanced colorectal cancer (CRC) often prove to be resistant to current treatment regimens, due to the evolving tumor microenvironment. Chemotherapy-dominated multi-modal therapeutic strategies based on the specific CRC microenvironment open a new horizon for eradicating colorectal tu...
ORGANISM(S): Mus musculus (Mouse) 
2025-05-07 | PXD059728 | Pride
In situ microenvironment response Colorectal cancer treatment. Multi-modal therapy Arsenic valence transition 
UnknownAncestral retrovirus envelope protein ERVWE1 upregulates circ_0001810, a potential biomarker for schizophrenia, and induces neuronal mitochondrial dysfunction via activating AK2.
Not available
S-EPMC11566632 | biostudies-literature
UnknownCaptive ERVWE1 triggers impairment of 5-HT neuronal plasticity in the first-episode schizophrenia by post-transcriptional activation of HTR1B in ALKBH5-m6A dependent epigenetic mechanisms.
Not available
S-EPMC10664518 | biostudies-literature
UnknownAncient dormant virus remnant ERVW-1 drives ferroptosis via degradation of GPX4 and SLC3A2 in schizophrenia.
Not available
S-EPMC10877354 | biostudies-literature
UnknownDomesticated HERV-W env contributes to the activation of the small conductance Ca2+-activated K+ type 2 channels via decreased 5-HT4 receptor in recent-onset schizophrenia.
Not available
S-EPMC10006216 | biostudies-literature
UnknownHuman endogenous retrovirus W family envelope protein (ERVWE1) regulates macroautophagy activation and micromitophagy inhibition via NOXA1 in schizophrenia.
Not available
S-EPMC12282446 | biostudies-literature
Sort   by:  
 Page size